[ Price : $8.95]
Johnson & Johnson says its Janssen unit is cooperating with regulators, healthcare organizations, and others in a multi-pronged ef...[ Price : $8.95]
FDA issues a guidance to help applicants develop labeling information demonstrating the connection between antihypertensive drugs ...[ Price : $8.95]
Stakeholders generally support the FDA position on clinical immunogenicity studies for biosimilar and interchangeable insulin prod...[ Price : $8.95]
CDER issues a list of 80 new and revised draft guidances it plans to publish in 2020.[ Price : $8.95]
FDA revises the CDER MAPP dealing with the review of ANDAs, amendments, and supplements.[ Price : $8.95]
FDA denies a Public Citizen petition seeking a narrower indication and labeling changes for Vanda's Hetlioz sleep disorder drug.[ Price : $8.95]
The California Superior Court orders Johnson & Johnson to pay $343.99 million in penalties for false and deceptive marketing of it...[ Price : $8.95]
FDA warns R&B Medical Group about HCT/P deviations in its work as a contract testing laboratory.